Etybenzatropine

Clinical data
Routes of administration	Oral, IM, IV
ATC code	N04AC30 (WHO)
Identifiers
IUPAC name (3-endo)-3-(Diphenylmethoxy)-8-ethyl-8-azabicyclo[3.2.1]octane
CAS Number	524-83-4 Y
PubChem CID	71637
ChemSpider	16736129 Y
UNII	G1X2X9N95N
KEGG	D04087 Y
CompTox Dashboard (EPA)	DTXSID50905096
Chemical and physical data
Formula	C22H27NO
Molar mass	321.464 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c3ccccc3)c4ccccc4
InChI InChI=1S/C22H27NO/c1-2-23-19-13-14-20(23)16-21(15-19)24-22(17-9-5-3-6-10-17)18-11-7-4-8-12-18/h3-12,19-22H,2,13-16H2,1H3/t19-,20+,21+ Y Key:PHTMLLGDZBZXMW-AERCQKQUSA-N Y
(verify)

Etybenzatropine (INN), also known as ethybenztropine (USAN, BAN) and tropethydrylin, is an anticholinergic/antihistamine marketed under the trade names Panolid, Ponalid, and Ponalide, which is used as an antiparkinsonian agent.^[1] Like its analogue benzatropine, it may act as a dopamine reuptake inhibitor.^{[citation needed]}

See also[edit]

• Benzatropine

References[edit]